NCT04508231

Metabolic Consequences of Cross-sex Hormonal Treatment

Metabolic Consequences of Cross-sex Hormonal Treatment in Transgender Persons

• Status: Unknown
• Phase: —
• Study type: Observational
• Enrollment: 98 (estimated)
• Sponsor: Central Hospital, Nancy, France · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: —

Summary

Retrospective study in a single academic regional transgender referral center. Analyse VAT, body composition and metabolic parameters in non-obese transgender subjects one year after starting gender-affirming hormone therapy and in controls

Conditions

• Gender Dysphoria

Interventions

Type	Name	Description
OTHER	Gender-affirming hormone therapy	Gender-affirming hormone therapy according to the recommendations of the Endocrine Society

Timeline

• Start date: 2020-07-24
• Primary completion: 2021-12-01
• Completion: 2021-12-01
• First posted: 2020-08-11
• Last updated: 2020-08-11

Locations

1 site across 1 country: France